Will JP Morgan’s AI Advisor Be a Winner?
JPMorgan Chase is rolling out “JPM WealthAI for high-net-worth clients.…
Buy
51
KRYS Quote, Financials, Valuation and Earnings
Last price:
$164.57
Seasonality move
:
21.08%
Day range:
$154.11 - $167.35
52-week range:
$141.72 - $219.34
Dividend yield:
0%
P/E ratio:
55.18x
P/S ratio:
16.87x
P/B ratio:
5.04x
Volume:
426.7K
Avg. volume:
316.8K
1-year change:
-8.3%
Market cap:
$4.8B
Revenue:
$290.5M
EPS (TTM):
$2.99
KRYS Analysts' Consensus Rating
The 9 analysts providing 12-month price projections for Krystal Biotech shares anticipate an average target of $214.80, ranging from a low estimate of $195.00 to a high estimate of $245.00. This average target implies a growth of 30.18% compared to the current stock price of $165.00.
Consensus Price Target
$214.80
Highest Price Target
$245.00
Lowest Price Target
$195.00
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Analyst Ratings
| 6M Ago | 1M Ago | Current | |
|---|---|---|---|
| Buy | 7 | 8 | 8 |
| Hold | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 |
| Consensus | Buy | Buy | Buy |
KRYS Recommendation Trends
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Revolve Group Stock a Buy, Sell or Hold?
Recently, Revolve Group (NYSE:RVLV) management delivered some fairly positive business…
Is Bloom Energy Stock a Buy, Sell or Hold?
While already interesting as the world moves toward greener energy…
Stock Ideas
Sell
45
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Sell
50
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 38x
Alerts
Buy
52
RGC alert for Apr 12
Regencell Bioscience Holdings [RGC] is up 29.14% over the past day.
Buy
52
SLP alert for Apr 12
Simulations Plus [SLP] is up 26.73% over the past day.
Buy
89
GDXU alert for Apr 12
MicroSectors Gold Miners 3X Leveraged ETN [GDXU] is up 15.9% over the past day.
